Losartan Does Not Cause Double Vision
Losartan is not associated with double vision (diplopia) as a recognized adverse effect. The FDA drug label for losartan does not list diplopia among its reported adverse reactions, and there is no clinical evidence linking this ARB to visual disturbances of this nature 1.
What the Evidence Shows
FDA-Approved Safety Profile
The comprehensive adverse event data from losartan clinical trials involving over 3,300 patients with hypertension and 4,058 total patients/subjects found no reports of double vision 1. The most common adverse events (≥2% incidence) were:
- Dizziness (3%)
- Upper respiratory infection (8%)
- Nasal congestion (2%)
- Back pain (2%)
Postmarketing surveillance has identified additional rare adverse reactions, but diplopia is notably absent from this list 1.
Ocular Effects Are Actually Beneficial
Research demonstrates that losartan has positive effects on ocular circulation rather than harmful ones:
- Increases choroidal blood flow: Losartan significantly increased fundus pulsation amplitude by 11% in healthy subjects 2
- Reduces intraocular pressure: Studies show losartan decreases IOP through mechanisms independent of blood pressure reduction, confirming a specific ocular effect 3
- Therapeutic for corneal fibrosis: Topical losartan is being investigated as a treatment for corneal scarring, with studies showing improved corneal transparency 4, 5, 6
Important Clinical Distinctions
What Could Be Causing Double Vision Instead
If a patient on losartan reports diplopia, consider these alternative causes:
Cardiovascular-related causes:
- Stroke or transient ischemic attack (losartan is used in patients with cardiovascular risk factors)
- Atrial fibrillation with embolic events (noted as a cardiac adverse event in losartan trials, though rare) 1
Neurological causes:
Other medication effects:
- Beta-blockers (if used concomitantly) can cause various visual disturbances 9
- Other antihypertensive agents in combination therapy
Common Pitfall to Avoid
Do not attribute diplopia to losartan simply because the patient is taking it. The temporal association does not establish causation. Patients on losartan typically have hypertension, diabetes, or cardiovascular disease—all conditions that independently increase risk for neurological and vascular events that can cause diplopia.
Clinical Recommendation
If a patient on losartan develops double vision, conduct a thorough neurological and ophthalmological evaluation to identify the true cause rather than discontinuing an effective antihypertensive medication. Losartan provides proven cardiovascular and renal protective benefits, particularly in diabetic nephropathy and hypertensive patients with left ventricular hypertrophy 10, 11, 12, 13, 14, 15, 1.
The medication should only be discontinued if a comprehensive workup reveals no other cause and symptoms resolve with cessation—an extremely unlikely scenario given the absence of any documented association between losartan and diplopia.